Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

372 ARTÍCULOS , VIENDO DEL 166 AL 180

Hybrid-based multi-target ligands for the treatment of Alzheimer's disease

Rampa A, Belluti F, Gobbi S, Bisi A.

Curr Top Med Chem. 2011 Nov;11(22):2716-30. doi: 10.2174/156802611798184409.

Multitarget-directed ligands: innovative chemical probes and therapeutic tools against Alzheimer's disease

Bolognesi ML, Simoni E, Rosini M, Minarini A, Tumiatti V, Melchiorre C.

Curr Top Med Chem. 2011 Nov;11(22):2797-806. doi: 10.2174/156802611798184373.

1,8-Naphthyridine derivatives as cholinesterases inhibitors and cell Ca2+ regulators, a multitarget strategy for Alzheimer's disease

Egea J, de los Rios C.

Curr Top Med Chem. 2011 Nov;11(22):2807-23. doi: 10.2174/156802611798184418.

Multi-target-directed ligands in Alzheimer's disease treatment

Bajda M, Guzior N, Ignasik M, Malawska B.

Curr Med Chem. 2011;18(32):4949-75. doi: 10.2174/092986711797535245.

Challenges associated with curcumin therapy in Alzheimer disease

Belkacemi A, Doggui S, Dao L, Ramassamy C.

Expert Rev Mol Med. 2011 Nov 4;13:e34. doi: 10.1017/S1462399411002055.

Spotlight on rivastigmine transdermal patch: in dementia of the Alzheimer's type

Dhillon S.

Drugs Aging. 2011 Nov 1;28(11):927-30. doi: 10.2165/11207090-000000000-00000.

Long-term progression of Alzheimer's disease in patients under antidementia drugs

Gillette-Guyonnet S, Andrieu S, Nourhashemi F, Gardette V, Coley N, Cantet C, Gauthier S, Ousset PJ, Vellas B; REAL.FR study group.

Alzheimers Dement. 2011 Nov;7(6):579-92. doi: 10.1016/j.jalz.2011.02.009.

Relevance of the chronobiological and non-chronobiological actions of melatonin for enhancing therapeutic efficacy in neurodegenerative disorders

Cecon E, Markus RP.

Recent Pat Endocr Metab Immune Drug Discov. 2011 May;5(2):91-9. doi: 10.2174/187221411799015381.

Interacting with γ-secretase for treating Alzheimer's disease: from inhibition to modulation

Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Logroscino G, Santamato A, Greco A, Seripa D, Pilotto A.

Curr Med Chem. 2011;18(35):5430-47. doi: 10.2174/092986711798194351.

Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor

May PC, Dean RA, Lowe SL, Martenyi F, Sheehan SM, Boggs LN, Monk SA, Mathes BM, Mergott DJ, Watson BM, Stout SL, Timm DE, Smith Labell E, Gonzales CR, Nakano M, Jhee SS, Yen M, Ereshefsky L, Lindstrom TD, Calligaro DO, Cocke PJ, Greg Hall D, Friedrich S, Citron M, Audia JE.

J Neurosci. 2011 Nov 16;31(46):16507-16. doi: 10.1523/JNEUROSCI.3647-11.2011.

Targeting post-translational modifications on tau as a therapeutic strategy for Alzheimer's disease

Marcus JN, Schachter J.

J Neurogenet. 2011 Dec;25(4):127-33. doi: 10.3109/01677063.2011.626471.

Does memantine improve the gait of individuals with Alzheimer's disease?

Beauchet O, Allali G, Launay C, Fantino B, Annweiler C.

J Am Geriatr Soc. 2011 Nov;59(11):2181-2. doi: 10.1111/j.1532-5415.2011.03648.x.

Towards the prevention of potential aluminum toxic effects and an effective treatment for Alzheimer's disease

Percy ME, Kruck TP, Pogue AI, Lukiw WJ.

J Inorg Biochem. 2011 Nov;105(11):1505-12. doi: 10.1016/j.jinorgbio.2011.08.001. Epub 2011 Aug 19.

Toward a unifying hypothesis in the development of Alzheimer's disease

Balin B, Abrams JT, Schrogie J.

CNS Neurosci Ther. 2011 Dec;17(6):587-9. doi: 10.1111/j.1755-5949.2011.00269.x.

[Role of the blood-brain barrier in Alzheimer's disease]

Gosselet F, Candela P, Cecchelli R, Fenart L.

Med Sci (Paris). 2011 Nov;27(11):987-92. doi: 10.1051/medsci/20112711015. Epub 2011 Nov 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias